Literature DB >> 10597206

High-dose salvage chemotherapy. Germ-cell tumor treatment results in Germany.

O Rick1, W Siegert, J Beyer.   

Abstract

During the past 10 years, high-dose chemotherapy (HDCT) has emerged as a feasible and curative treatment option for patients with multiply relapsed and/or refractory germ-cell tumors. Increasing experience and the results from clinical trials have helped to optimize the application of HDCT and to define its role in the salvage concepts for germ-cell tumors.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10597206     DOI： 10.1002/(sici)1097-0215(19991210)83:6<839::aid-ijc26>3.0.co;2-a

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


  3 in total

Review 1.  The role of high-dose chemotherapy in relapsed germ cell tumors.

Authors:  O Rick; C Kollmannsberger; J T Hartmann; T Braun; W Siegert; C Bokemeyer; J Beyer
Journal:  World J Urol       Date:  2004-03-18       Impact factor: 4.226

2.  Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [(18)F]FDG PET.

Authors:  C Bokemeyer; C Kollmannsberger; K Oechsle; B M Dohmen; A Pfannenberg; C D Claussen; R Bares; L Kanz
Journal:  Br J Cancer       Date:  2002-02-12       Impact factor: 7.640

3.  Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours.

Authors:  I A McNeish; E J Kanfer; R Haynes; C Giles; S J Harland; D Driver; G J S Rustin; E S Newlands; M J Seckl
Journal:  Br J Cancer       Date:  2004-03-22       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.